Literature DB >> 10871771

Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue.

C A Messam1, E O Major.   

Abstract

The predominant cell types infected by HIV-1 in AIDS associated encephalopathy are cells of the macrophage/microglial lineage. There has been consistent evidence, however, that astrocytes also become infected although not at the same frequency or level of multiplication as microglial cells. HIV-1 antigens and/or nucleic acid have been identified in astrocytes in brain autopsy tissue from both adult and pediatric AIDS cases. In cell cultures, HIV-1 infection of astrocytes results in an initial productive but non-cytopathogenic infection that diminishes to a viral persistence or latent state. Understanding the nature of HIV-1 infection of astrocytes, which represents the largest population of cells in the brain, will contribute to the understanding of AIDS encephalopathy and the dementia that occurs in nearly one-quarter of all AIDS patients.

Entities:  

Mesh:

Year:  2000        PMID: 10871771

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  28 in total

1.  In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats.

Authors:  A Hein; J P Martin; R Dörries
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Fluorescently-labeled RNA packaging into HIV-1 particles: Direct examination of infectivity across central nervous system cell types.

Authors:  Ruqiang Xu; Nazira El-Hage; Seth M Dever
Journal:  J Virol Methods       Date:  2015-08-10       Impact factor: 2.014

Review 3.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 4.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

5.  HIV-1 Tat Induces Unfolded Protein Response and Endoplasmic Reticulum Stress in Astrocytes and Causes Neurotoxicity through Glial Fibrillary Acidic Protein (GFAP) Activation and Aggregation.

Authors:  Yan Fan; Johnny J He
Journal:  J Biol Chem       Date:  2016-09-08       Impact factor: 5.157

6.  Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins.

Authors:  Ashok Chauhan; Sven Hahn; Suzanne Gartner; Carlos A Pardo; Senthil Kumar Netesan; Justin McArthur; Avindra Nath
Journal:  FASEB J       Date:  2006-12-28       Impact factor: 5.191

7.  Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression.

Authors:  Ying Liu; Yinghua Niu; Lu Li; Khalid A Timani; Victor L He; Chris Sanburns; Jiafeng Xie; Johnny J He
Journal:  J Neurovirol       Date:  2019-04-24       Impact factor: 2.643

8.  Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Authors:  M C Strain; S Letendre; S K Pillai; T Russell; C C Ignacio; H F Günthard; B Good; D M Smith; S M Wolinsky; M Furtado; J Marquie-Beck; J Durelle; I Grant; D D Richman; T Marcotte; J A McCutchan; R J Ellis; J K Wong
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

9.  Simian fetal brain progenitor cells for studying viral neuropathogenesis.

Authors:  Naoko Iwata; Hiroaki Yoshida; Minoru Tobiume; Fumiko Ono; Takuya Shimazaki; Tetsutaro Sata; Noriko Nakajima
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

10.  DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication.

Authors:  Veerasamy Ravichandran; Eugene O Major
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.